mRNA COVID-19 vaccines well-tolerated in women who are pregnant, lactating, or planning pregnancy: Study
A study of more than 17,000 pregnant and lactating individuals showed that coronavirus disease 2019 (COVID-19) vaccines were well-tolerated among individuals who were pregnant, lactating, or planning pregnancy.
The study included 7,809 individuals who were pregnant, 6,815 individuals who were lactating, and 2,901 individuals who were neither pregnant nor lactating but planning pregnancy in the near future at the time of their first vaccine dose.
Most individuals received Pfizer’s BioNTech BNT162b2 vaccine (61.9%) or Moderna’s mRNA-1273 vaccine (37.8%)
Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout. Alisa Kachikis, et al. JAMA Netw Open. 2021;4(8):e2121310. doi:10.1001/jamanetworkopen.2021.21310